Antiatherogenic Effects of Thiazolidinediones?
نویسندگان
چکیده
منابع مشابه
Antiatherogenic effects of thiazolidinediones?
Treatment of type 2 diabetes mellitus (DM) is directed at relieving symptoms of hyperglycemia and reducing the incidence of diabetes-associated pathologies. Complications of atherosclerosis, including myocardial infarction and stroke, are the most common causes of death in diabetic patients. Thiazolidinediones (TZDs) represent a relatively recent addition to the arsenal of pharmaceutical option...
متن کاملThe anti-atherogenic effects of thiazolidinediones.
The thiazolidinediones (TZDs) rosiglitazone (ROS) and pioglitazone (PIO) are insulin-sensitising agents widely used to treat patients with type 2 diabetes mellitus (T2DM). Thiazolidinediones significantly improve glycaemic control in diabetics by reduced fasting glucose, insulin and glycated haemoglobin and they delay the progression of insulin resistance/impaired glucose tolerance into T2DM. I...
متن کاملDietary taurine supplementation: hypolipidemic and antiatherogenic effects
Taurine supplementation may prove to be a safe and convenient method to reverse high blood holesterol and the associated rise in atherosclerosis. Although human studies are limited, experiments sing animal models provide extensive proof of the hypolipidemic and antiatherogenic effects of aurine. Examples of these animal models involve feeding with high-fat diets, genetically determined r herita...
متن کاملMetabolic and additional vascular effects of thiazolidinediones.
Several cardiovascular risk factors (dyslipidaemia, hypertension, glucose intolerance, hypercoagulability, obesity, hyperinsulinaemia and low-grade inflammation) cluster in the insulin resistance syndrome. Treatment of these individual risk factors reduces cardiovascular complications. However, targeting the underlying pathophysiological mechanisms of the insulin resistance syndrome is a more r...
متن کاملThiazolidinediones: antidiabetic drugs with cardiovascular effects.
cardiovascular morbidity and mortality at least four times higher compared to patients without diabetes. Moreover, it is well established nowadays that the cardiovascular risk of diabetic patients without a history of a prior myocardial infarction is similar to the risk of nondiabetic patients who have already had one. Hence, the reduction of cardiovascular risk in type 2 diabetic patients usin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arteriosclerosis, Thrombosis, and Vascular Biology
سال: 2001
ISSN: 1079-5642,1524-4636
DOI: 10.1161/01.atv.21.3.295